Company

CERES BRAIN Therapeutics

Pharmaceutical Manufacturing Paris, Fr 9 employees

Employees: 9
Contacts: 3
Emails: 3

www.ceres-brain.com LinkedIn

CERES BRAIN Therapeutics Overview

Headquarters: Paris, Fr
Website: www.ceres-brain.com
Industry: Pharmaceutical Manufacturing
Employees: 9
Founded: 2019
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

Representative jobs

About CERES BRAIN Therapeutics

CERES BRAIN Therapeutics is dedicated to treat cerebral diseases with a first focus on rescuing suffering neurons with creatine through an innovative "creatine-to-brain" concept. The first indications are Creatine Transporter Deficiency syndrome, a disabling condition with no treatment affecting children and Amyotrophic Lateral Sclerosis. The lead compound CBT101 demonstrated efficacy in a preclinical models models as well as a large cerebral and neuronal distribution in primate. The CMC reached noticeable milestones with several GMP batches produced. Other mitochondriopathies are in the Ceres's pipeline. CERES BRAIN Therapeutics has already raised up to 12M€ to move towards the clinical program.

CERES BRAIN Therapeutics Contact Details

People in AeroLeads: 3
With contact data: 3
Email contacts: 3; 100.0% coverage

CERES BRAIN Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Marc Vincenti		Boulogne-billancourt, ÎLe-de-france, France	Email
Camille Roucairol	Pharmaceutical Development Director at Ceres Brain Therapeutics	Colombes, ÎLe-de-france, France	Email
Denis Ravel	Founder and Managing Director at Initial R&D Consulting	Greater Paris Metropolitan Region, France	Email